Immunotherapy has revolutionized oncology remarkably and gained great improvements in
cancer therapy. However, tumor immunotherapy still encounters serious challenges …

The past decades have witnessed great progress in cancer immunotherapy, which has
profoundly revolutionized oncology, whereas low patient response rates and potential …

Conspectus Therapeutic manipulation of the immune system against cancer has
revolutionized the treatment of several advanced-stage tumors. While many have benefited …

Cancer immunotherapy has witnessed significant advances in the past decade, however
challenges associated with immune‐related adverse effects and immunosuppressive tumor …

Immunotherapy provides a new avenue for combating cancer. Current research in
anticancer immunotherapy is primary based on T cell-mediated cellular immunity, which can …

Immunotherapy that harnesses the human immune system to fight cancer has received
widespread attention and become a mainstream strategy for cancer treatment. Cancer …

Nanomaterials offer unique advantages as drug-delivery vehicles for cancer therapeutics.
For immuno-oncology applications, cancer nanomedicine should be developed beyond …

Cancer immunotherapy is quickly growing to be the fourth most important cancer therapy,
after surgery, radiation therapy, and chemotherapy. Immunotherapy is the most promising …

The host immune system possesses an intrinsic ability to target and kill cancer cells in a
specific and adaptable manner that can be further enhanced by cancer immunotherapy …

Therapeutic targeting of the immune system, including chimeric antigen receptor-T cell
therapy, immune checkpoint blockade therapy, neoantigen vaccines, and small molecule …